jean-rené pallandre
INSERM U1098 Interactions Hôte-Greffon-Tumeur & Ingénierie Cellulaire et Génique
Besançon, France
Review Editor
Cancer Immunity and Immunotherapy
Editors
INSERM U1098 Interactions Hôte-Greffon-Tumeur & Ingénierie Cellulaire et Génique
Besançon, France
Review Editor
Cancer Immunity and Immunotherapy
Hangzhou City University
Hangzhou, China
Review Editor
Cancer Immunity and Immunotherapy
Department of Computational Biology, St. Jude Children's Research Hospital
Memphis, United States
Review Editor
Cancer Immunity and Immunotherapy
First Affiliated Hospital of Guangzhou Medical University
Guangzhou, China
Review Editor
Cancer Immunity and Immunotherapy
Sun Yat-sen University
Guangzhou, China
Review Editor
Cancer Immunity and Immunotherapy
Catholic University of the Sacred Heart
Milano, Italy
Review Editor
Cancer Immunity and Immunotherapy
AstraZeneca (United States)
Wilmington, United States
Review Editor
Cancer Immunity and Immunotherapy
Case Western Reserve University
Cleveland, United States
Review Editor
Cancer Immunity and Immunotherapy
University of California, Irvine
Irvine, United States
Review Editor
Cancer Immunity and Immunotherapy
CSL Behring AG
Bern, Switzerland
Review Editor
Cancer Immunity and Immunotherapy
National University of Sciences and Technology (NUST)
Islamabad, Pakistan
Review Editor
Cancer Immunity and Immunotherapy
Fundacion Agencia Aragonesa para la Investigacion y el Desarrollo
Zaragoza, Spain
Review Editor
Cancer Immunity and Immunotherapy
Vall d'Hebron University Hospital
Barcelona, Spain
Review Editor
Cancer Immunity and Immunotherapy
Nanobiotix (France)
Paris, France
Review Editor
Cancer Immunity and Immunotherapy
Kyung Hee University
Seoul, Republic of Korea
Review Editor
Cancer Immunity and Immunotherapy
Chungnam National University Sejong Hospital
Sejong, Republic of Korea
Review Editor
Cancer Immunity and Immunotherapy